1. Home
  2. OCS vs PRO Comparison

OCS vs PRO Comparison

Compare OCS & PRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • PRO
  • Stock Information
  • Founded
  • OCS 2003
  • PRO 1985
  • Country
  • OCS Switzerland
  • PRO United States
  • Employees
  • OCS N/A
  • PRO N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • PRO EDP Services
  • Sector
  • OCS Health Care
  • PRO Technology
  • Exchange
  • OCS Nasdaq
  • PRO Nasdaq
  • Market Cap
  • OCS 956.4M
  • PRO 863.3M
  • IPO Year
  • OCS N/A
  • PRO 2007
  • Fundamental
  • Price
  • OCS $17.64
  • PRO $15.72
  • Analyst Decision
  • OCS Strong Buy
  • PRO Strong Buy
  • Analyst Count
  • OCS 3
  • PRO 10
  • Target Price
  • OCS $35.33
  • PRO $28.10
  • AVG Volume (30 Days)
  • OCS 13.6K
  • PRO 852.3K
  • Earning Date
  • OCS 08-26-2025
  • PRO 07-31-2025
  • Dividend Yield
  • OCS N/A
  • PRO N/A
  • EPS Growth
  • OCS N/A
  • PRO N/A
  • EPS
  • OCS N/A
  • PRO N/A
  • Revenue
  • OCS $847,333.00
  • PRO $336,006,000.00
  • Revenue This Year
  • OCS $10.23
  • PRO $10.27
  • Revenue Next Year
  • OCS $912.87
  • PRO $10.46
  • P/E Ratio
  • OCS N/A
  • PRO N/A
  • Revenue Growth
  • OCS N/A
  • PRO 7.97
  • 52 Week Low
  • OCS $10.79
  • PRO $13.61
  • 52 Week High
  • OCS $23.08
  • PRO $29.84
  • Technical
  • Relative Strength Index (RSI)
  • OCS 40.60
  • PRO 46.72
  • Support Level
  • OCS $17.27
  • PRO $15.43
  • Resistance Level
  • OCS $18.57
  • PRO $17.10
  • Average True Range (ATR)
  • OCS 0.53
  • PRO 0.70
  • MACD
  • OCS 0.01
  • PRO 0.07
  • Stochastic Oscillator
  • OCS 31.11
  • PRO 41.28

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About PRO PROS Holdings Inc.

Pros Holdings Inc provides software solutions that optimize shopping and selling experiences for both business-to-business and business-to-consumer companies across industry verticals in more than nearly 80 countries. Its PROS Platform is designed to help businesses create, optimize and market available offers and handle orders through both first- and third-party digital channels. The firm generates key revenue form the United States of America, Germany, The rest of Europe, Africa, Asia-Pacific, and Middle East regions.

Share on Social Networks: